The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Looking for Brexit-proof portfolios? Try drugs, alcohol and tobacco

Wed, 29th Jun 2016 14:32

By Tricia Wright and Vikram Subhedar

LONDON, June 29 (Reuters) - Health, safety and even sometraditional 'sin stocks' have already shown signs of weatheringBrexit-related storms in European equity markets over the pastweek.

The flight to safety in the aftermath of last week's Brexitvote is sending investors scurrying back into healthcare andconsumer-related stocks that have shielded them from nearlyevery big market dislocation of the past five years.

On Wednesday, European healthcare became the first majorregional sector to recover all its post-Brexit losses, helpedlargely by the big UK bellwethers. Food and beverage stocks arepoised to follow.

Stocks such as AstraZeneca PLC, Diageo PLC and British American Tobacco PLC are up between 7percent and 11 percent since last Thursday's close.

They have led the broader market's recovery after more than$3 trillion was knocked off the value of global stocks in thetwo-day selloff that followed Britain's unexpected decision toleave the European Union.

The combination of dependable profits, dividends andexpectations that the weaker pound and euro will spur earningsupgrades for firms that sell mostly to consumers outside the UKand Europe has underpinned their resilience.

"There are three things at work but I think the first is thereach for dollar earnings," said Eric Moore, who runs the MitonIncome Fund from London.

"In a world where GDP is probably slowing everywhere,irrespective of Brexit, there's just more uncertainty," saidMoore, adding the relative stability of the so-called defensivesectors, whose profits are less reliant on economic growth,brightens their appeal.

The rally in bluechip healthcare and food and beveragestocks has even pushed the UK's FTSE 100 to less than apercent below its pre-Brexit level. In US dollar terms the indexis still more than 10 percent lower.

Outside of the UK, German real estate has found favour.Shares of Vonovia and Deutsche Wohnen areboth higher than where they were before last week's vote.

Both companies are focused on residential properties inGermany where low rates have contributed to steady price riseswhile low vacancy rates have put a floor under rents.

Gold mining stocks Rangold Resources and Fresnillo are up more than 20 percent as demand for the preciousmetal surged.

For a list of major European stocks that are above wherethey closed last Thursday see: http://reut.rs/295Lkwm

Goldman Sachs, which slashed its economic forecasts for theUK and Europe after the vote, now expects earnings in 2016 forthe Stoxx 600 to contract 5 percent.

Still, with German 10-year bund yields below zero the U.S.bank says equities offer value compared with other assets.

But given worries over the health of European banks andgrowth Goldman warns against broad-based buying and recommendsinvestors stick with food, beverage and tobacco and healthcareshares.

"The attractions of the more defensive or stable parts inequities are clear," said Goldman strategists in a note toclients.

(Reporting by Vikram Subhedar and Tricia Wright, additionalreporting by Tina Bellon in Frankfurt; Editing by Mike Dolan andToby Chopra)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.